When AXP2258 was added with nintedanib in cultured slow IPF lung fibroblasts, statistically significant reductions in αSMA but not collagen 1 protein levels were observed compared with the nintedanib alone control group (Fig. 4B,E). This evidence concerns the gene ACTA1 and idiopathic pulmonary fibrosis.